Collins Stewart Maintains Buy on Intuitive Surgical

Collins Stewart is out with its report today on Intuitive Surgical ISRG, maintaining Buy. In a note to clients, Collins Stewart writes, "Over the past couple of days, we attended the annual World Robotic Society conference, which is focused on ISRG's da Vinci system. Overall, our due diligence points toward favorable trends and dynamics in robotics, and we came away further convinced that ISRG is the best long-term growth story in MedTech." Collins Stewart maintains a $400 PT on ISRG. Shares of ISRG closed Tuesday at $365.75.